Naloxone
ID: 9594CS25Q0020Type: Solicitation
Overview

Buyer

COURT SERVICES AND OFFENDER SUPERVISION AGENCYCOURT SERVICES AND OFFENDER SUPERVISION AGENCYCOURT SERVICES OFFENDER SUPV AGCYWASHINGTON, DC, 20004, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/afba69212f87409ab6361e814d2ebe1e/view
Timeline
    Description

    The Court Services and Offender Supervision Agency (CSOSA) is seeking proposals for the procurement of 450 packages of Naloxone 2 Dose Nasal Spray, as outlined in their solicitation. This procurement aims to ensure the availability of this critical medication, which is essential for reversing opioid overdoses, thereby supporting public health and safety initiatives. The contract will be awarded under a firm-fixed price purchase order, with a submission deadline for quotations set for January 7, 2025. Interested vendors can direct inquiries to Matthew Collins at matthew.collins@csosa.gov or by phone at 202-369-7635 for further details on compliance and submission requirements.

    Point(s) of Contact
    Matthew Collins
    (202) 369-7635
    matthew.collins@csosa.gov
    Files
    Title
    Posted
    9594CS25Q0020 AMD 0001.pdf
    This document is Amendment 0001 to Solicitation 9594CS25Q0020 issued by the Court Services and Offender Supervision Agency regarding the procurement of Naloxone. The amendment outlines the acknowledgment requirements for any proposals, which must be communicated via specific methods prior to the deadline. It details the necessary contractor information to be included in submissions, replacing section L.1.2, which now specifies required details such as the contractor's contact information, Tax Identification Number, Unique Entity Identification, Cage Code, and a validity statement for the quotation. Additionally, a new section L.1.3 mandates information about the manufacturer of the quoted product. The amendment emphasizes that acknowledgment of receipt must be submitted with proposals to avoid rejection due to noncompliance. Overall, this document aims to clarify submission requirements and ensure compliance in the procurement process.
    Attachment J-1 FAR 52.212-3 Offeror Reps & Certs.docx
    The document outlines the Offeror Representations and Certifications required for federal solicitations, specifically focusing on commercial products and services. It details the criteria for small businesses, including those owned by economically disadvantaged women and service-disabled veterans, alongside requirements for various certifications, such as compliance with the Buy American Act and prohibitions on the use of certain telecommunications and technologies. The sections emphasize the necessity for offerors to confirm their business status, confirm integrity regarding federal contracts, disclose tax liabilities, report any previous contracts, and observe restrictions related to operations in Sudan and dealings with Iran. Overall, the document serves as a comprehensive guide for prospective contractors to ensure compliance with federal regulations and eligibility for government contracts while maintaining transparency and ethical business practices. The structured format allows offerors to indicate their compliance with specific requirements clearly, ensuring a thorough understanding of obligations under the given solicitation.
    Solicitation 9594CS25Q0020.pdf
    The document outlines a federal solicitation for the procurement of 450 packages of Naloxone 2 Dose Nasal Spray by the Court Services and Offender Supervision Agency (CSOSA). It specifies the required specifications, delivery timelines, and the contractual agreement structure, categorized under a firm-fixed price purchase order. The primary NAICS code for this contract is 325412, indicating it involves pharmaceutical preparation manufacturing, with a small business size standard of 1,300 employees. Key points include the requirement for vendors to submit their quotations by January 7, 2025, and details about the invoice processing via the Department of Treasury's Invoice Processing Platform. The solicitation emphasizes compliance with various federal regulations and clauses surrounding contractor conduct, payment processing, and delivery expectations, ensuring the procurement services align with government standards. The document is structured into sections addressing requisition details, supplies, specifications, delivery instructions, and administrative requirements, guiding potential contractors through the bidding process while ensuring adherence to government procurement policies.
    Lifecycle
    Title
    Type
    Naloxone
    Currently viewing
    Solicitation
    Similar Opportunities
    Treatment Services 2025-2026
    Administrative Office Of The Us Courts
    The Administrative Office of the U.S. Courts is preparing to procure treatment services for federal defendants and individuals under supervision through Blanket Purchase Agreements. The procurement will encompass a range of services, including outpatient mental health and substance abuse treatment, counseling, detoxification, and transportation, among others, with specific requirements to be detailed in future solicitations. These services are critical for supporting the rehabilitation and supervision of individuals within the federal judicial system, and solicitations may be issued at any time throughout the year based on district needs. Interested vendors should contact the Chief Probation or Pretrial Services Officer in their respective district for further information and to be placed on a mailing list, with inquiries directed to TreatmentServicesQuestions@ao.uscourts.gov.
    Atropine and Pralidoxime Chloride, 'Duodote Kit"
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of the Assistant Secretary for Administration, is seeking quotes for the procurement of Atropine and Pralidoxime Chloride Autoinjectors, known as the "Duodote Kit." The requirement includes a total of 171 boxes, each containing 30 autoinjectors, to be delivered to the DHHS Receiving Dock located in Perry Point, Maryland. These autoinjectors are critical for emergency medical treatment, particularly in cases of organophosphate poisoning. Interested vendors should direct their inquiries to Tim Bouchelle at Timothy.Bouchelle@hhs.gov or by phone at 443-947-6039, with no set-aside restrictions applicable to this solicitation.
    Ondansetron 4MG and 8MG
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Ondansetron. This contract will establish a national supply source to provide Ondansetron HCL 4 and 8MG Tablets for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The projected solicitation date is March of 2023.
    Trazodone - Solicitation
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting offers for Trazodone HCL tablets in various dosages and bottle counts. This procurement aims to fulfill substantial pharmaceutical supply needs, emphasizing compliance with technical and quality requirements as outlined in the solicitation documents. The solicitation, identified as SPE2D2-26-R-0003, mandates electronic submissions via the Defense Logistics Agency Internet Bid Board System (DIBBS) by December 12, 2025, at 3:00 PM EST, with no alternative submission methods accepted. Interested parties can reach out to Nancy Fernandez at nancy.fernandez@dla.mil or Jason Wray at jason.wray@dla.mil for further inquiries.
    COMPREHENSIVE MEDICAL SERVICES - FCI OXFORD
    Justice, Department Of
    The Department of Justice, specifically the Federal Bureau of Prisons, is seeking proposals for Comprehensive Medical Services at the Federal Correctional Institution in Oxford, Wisconsin. The procurement aims to secure a single award for a range of medical services, including inpatient and outpatient facility and physician services, under an indefinite delivery/requirements contract with firm-fixed unit pricing. This contract will consist of a Base Year and four 12-month option years, with estimated quantities of 94 inpatient days and 246 outpatient visits for the Base Year. Interested parties should monitor the official U.S. Government contract opportunities website for the solicitation, which will be available on or about November 14, 2025, and must ensure they are registered in the System for Award Management (SAM) database. For inquiries, contact LaShundra D. Thomas at ldthomas@bop.gov or call 202-598-6077.
    6505--Zonisamide Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers for a Firm Fixed Price, Indefinite-Delivery Requirements contract for Zonisamide Capsules in 25mg, 50mg, and 100mg dosages. Offerors are required to provide pricing for a base year and four option years, submit a 0.5% Cost Recovery Fee, and comply with stringent packaging and barcoding standards, including adherence to the Drug Supply Chain Security Act (DSCSA) and National Drug Code (NDC) requirements. These pharmaceutical products are crucial for the healthcare services provided to veterans and military personnel through the VA and DoD Pharmaceutical Prime Vendor Programs. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details, and ensure they meet all compliance and registration requirements, including current SAM registration.
    FY26 GSU THC Pharmaceutical Medication Returns [base+3options]
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Indian Health Service's Navajo Area, is soliciting proposals for pharmaceutical medication returns at the Tohatchi Health Center in New Mexico. This procurement, set aside for small businesses, requires offerors to provide waste disposal services, including waste characterization, container provision, staff training, and ongoing support, with a contract period spanning from January 1, 2026, to December 31, 2026, and options for three additional years. The services are critical for managing hazardous pharmaceutical waste in compliance with regulatory standards, ensuring safe disposal and environmental protection. Interested parties must submit their proposals by December 19, 2025, at 3:00 PM MS, and can direct inquiries to Ken Parrish at Ken.Parrish@ihs.gov or by phone at 928-871-1342.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Nicotine Lozenges MINI (VA-26-00020754)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Nicotine Mini Lozenges, specifically under solicitation number 36E79726R0007. This contract aims to ensure an uninterrupted supply of nicotine lozenges for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS), with a contract duration of one year and four optional one-year extensions. The estimated annual requirements include 166,791 bottles of 2mg lozenges and 138,276 bottles of 4mg lozenges, which will be distributed through the VA and DOD Pharmaceutical Prime Vendor Programs. Interested offerors should note that the solicitation will be electronically issued around December 18, 2025, with a tentative closing date of January 1, 2026, and can direct inquiries to Billy Fong at billy.fong@va.gov or by phone at 708-786-4992.
    Second Chance Act Goods and Services
    Administrative Office Of The Us Courts
    The Administrative Office of the U.S. Courts is preparing to procure goods and services under the Second Chance Act, aimed at supporting federal defendants and individuals under supervision. This procurement will utilize Blanket Purchase Agreements and may include a range of services such as cognitive behavioral therapy, job training, transitional housing, and more, with solicitations potentially issued throughout the year based on district needs. The importance of these services lies in their role in facilitating rehabilitation and reintegration into society for individuals under federal supervision. Interested vendors should contact the Chief Probation or Pretrial Services Officer in their respective district for further information and to be placed on a mailing list, with the primary contacts for this opportunity being Ryan Sharp at ryansharp@insp.uscourts.gov and William Ware at williamware@ao.uscourts.gov.